The performance of companies tied to flagship drugs like Viagra presents a challenging investment landscape . While the initial rise of copyright, fueled by Viagra's unprecedented popularity, generated substantial returns, the loss of exclusivity in key regions has introduced considerable risk . Investors are now grappling with the consequences … Read More